The company has collaborated with the “father of cannabis” Professor Raphi Mechoulam to identify of HUM-217.
President of CLEAR UK, Peter Reynolds, discusses CBD, medical and recreational cannabis in the UK.
Oxford Cannabinoid Technologies has signed agreements to accelerate the development of a pain management solution using phytocannabinoids.
The deal will see the companies develop new products to target specific medical conditions.
Aleiya Lonsdale, head of marketing at Lab Innovations 2021, looks at why labs will need to become more adaptable to the expected growth in the market.
CBD Science has announced the launch of a funding raise to help advance cannabis-based treatments for cancer pain.
Oxford Cannabinoid Technologies has signed a worldwide exclusive licence agreement with Canopy Growth Corporation.
Grow and Sanoid aim to supply high quality cannabis products at an affordable price point for patients.
The medicine will now be available on prescription for patients in the UK.
Elite Growth is on a mission to transform the global medical cannabis market. Its team of experts and industry veterans reveal how.
